Atlas Venture Fund X L.P. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-06 5:00 pm Sale |
2022-11-23 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 1,498,635 3.000% |
-665,402 (-30.75%) |
Filing |
| 2022-09-14 5:06 pm Sale |
2022-09-12 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 2,164,037 4.400% |
-360,829 (-14.29%) |
Filing |
| 2020-09-17 4:50 pm Sale |
2020-09-15 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 2,524,866 6.300% |
-436,607 (-14.74%) |
Filing |
| 2020-07-07 5:11 pm Sale |
2020-07-02 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 2,961,473 7.500% |
-436,607 (-12.85%) |
Filing |
| 2020-06-19 5:03 pm Sale |
2020-06-16 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 3,398,080 8.600% |
-436,507 (-11.38%) |
Filing |